SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 15, 2003
DEPOMED, INC.
(Exact name of registrant as specified in its charter)
California |
|
001-13111 |
|
94-3229046 |
(State of Incorporation or Organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
1360 OBrien Drive, Menlo Park, California |
|
94025 |
||
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone no., including area code: (650) 462-5900
NOT APPLICABLE
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits
Exhibits
99.1 DepoMed, Inc. Press Release issued on May 15, 2003
Item 9. Regulation FD Disclosure
On May 15, 2003, DepoMed, Inc. issued a press release announcing its financial results for the period ended March 31, 2003. The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
The information provided in this Current Report on Form 8-K is being provided under Item 12 of Form 8-K.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DEPOMED, INC. |
||
|
|
|
|
/s/ John F. Hamilton |
|
|
John F. Hamilton |
|
|
Vice President - Finance and |
|
|
Chief Financial Officer |
|
Date: May 16, 2003
3
EXHIBIT INDEX
Exhibit
99.1 DepoMed, Inc. Press Release issued on May 15, 2003